FDA grants EUA for Qorvo COVID-19 antigen test

By LabPulse.com staff writers

August 4, 2022 -- Qorvo announced Thursday that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its Omnia SARS-CoV-2 Antigen Test in point-of-care settings.

The test is authorized for the detection of nucleocapsid viral antigens from COVID-19 in nasal swab specimens taken within six days of symptom onset from those who are suspected of having COVID-19.

Individuals without symptoms or for whom there are other epidemiological reasons to suspect COVID-19 may also use the product to test twice over three days, with at least 24 hours and no more than 48 hours between tests.

The EUA expands the market for Qorvo beyond laboratories to include physicians' offices, urgent care centers, retail pharmacies, employee health testing, and any other locations where CLIA-waived tests can be performed, Qorvo said.

FDA grants EUA for two at-home COVID-19 tests
The U.S. Food and Drug Administration (FDA) on Tuesday announced it has authorized two COVID-19 antigen tests -- the Genabio COVID-19 Rapid Self-Test...
FDA issues EUA for Roche test to detect SARS-CoV-2, viral load
Roche on Wednesday announced that the U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for its Cobas SARS-CoV-2...
FDA issues EUA for Labcorp NGS test to detect SARS-CoV-2 strains
The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization for the Laboratory Corporation of America (Labcorp) VirSeq SARS-CoV-2...
FDA OKs Labcorp's over-the-counter COVID-19, RSV, flu test
The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) to Labcorp for the first nonprescription test that can detect...
FDA grants expanded use of ChromaCode's COVID-19 test
The U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization of ChromaCode's High-Definition Polymerase Chain Reaction (HDPCR)...

Copyright © 2022 LabPulse.com

Last Updated mp 8/4/2022 12:21:20 PM



Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current